CLEAR-AD U19 Diversity Scholars Program

Mayo Clinic researchers and colleagues from 13 other institutions around the country are pursuing multiethnic projects to identify targets for Alzheimer's disease treatment. The program seeks to identify the next generation of precision medicine biomarkers and potential novel therapeutic targets of Alzheimer's and related dementias in multiethnic populations. The program, called Centrally-Linked Longitudinal Peripheral Biomarkers of AD in Multiethnic Populations (CLEAR-AD), is funded by a five-year grant from the National Institute on Aging, part of the National Institutes of Health. The grant is expected to total $41 million. Learn more about the project on the AD Knowledge Portal website.

CLEAR-AD U19 Diversity Scholars is a 2-year program for early-career scientists from groups underrepresented in biomedical research. Scholars will receive an award of $25,000 per year to facilitate their participation in this program. Recent college graduates, graduate students and post-doctoral/clinical fellows are encouraged to apply. Early-stage faculty with an appointment at Mayo Clinic or Indiana University are also eligible. Mayo Clinic and Indiana University will each be accepting one U19 Diversity Scholar per year. Scholars will have access to a rich curriculum, along with formal mentorship. Scholars will also be integrated into a project within the U19 and participate in program meetings.